On May 1, 2018 Selecta Biosciences, Inc. (NASDAQ:SELB), a clinical-stage biopharmaceutical company focused on unlocking the full potential of biologic therapies by mitigating unwanted immunogenicity, reported that members of the Selecta management team will present at the following investor conferences (Press release, Selecta Biosciences, MAY 1, 2018, View Source [SID1234525928]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

The 43rd Annual Deutsche Bank Health Care Conference – 1.30 p.m. ET on Tuesday, May 8, 2018 in Boston.
UBS Global Healthcare Conference – 9:00 a.m. ET on Wednesday, May 23, 2018 in New York City.
Live and archived webcasts of the presentations will be available on the Investors & Media section of the Selecta website at www.selectabio.com.